Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less

被引:49
作者
Chi, Dennis S.
Ramirez, Pedro T.
Teitcher, Jerrold B.
Mironov, Svetlana
Sarasohn, Debra M.
Iyer, Revathy B.
Eisenhauer, Eric L.
Abu-Rustum, Nadeem R.
Sonoda, Yukio
Levine, Douglas A.
Brown, Carol L.
Aghajanian, Carol
Gershenson, David M.
Hoskins, William J.
Hricak, Hedvig
Barakat, Richard R.
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, Dept Radiol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Solid Tumor Serv, New York, NY 10021 USA
[3] MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX USA
[4] MD Anderson Canc Ctr, Dept Radiol, Houston, TX USA
关键词
D O I
10.1200/JCO.2007.12.2317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To compare surgeons' operative assessments of residual disease (RD) to those identified on postoperative computed tomography (CT) scans in patients with advanced ovarian carcinoma reported to have undergone optimal primary cytoreduction. Patients and Methods All patients at one of two institutions, who were scheduled to have primary surgery for presumed advanced ovarian cancer, were asked to consent to a postoperative CT scan if cytoreduction to <= 1 cm RD was reported. CT scan findings were graded using a qualitative analysis scale from 1 (normal) to 5 (definitely malignant). Results From January 2001 to September 2006, 285 patients were enrolled. A total of 78 patients met eligibility criteria and had postoperative CT scans. In 41 cases (52%), postoperative scan findings correlated with the surgical report of no RD more than 1 cm, and in seven cases (9%), the CT findings were indeterminate. In 10 cases (13%), more than 1 cm RD was noted by the radiologist as probably malignant, and in 20 cases (26%), definitely malignant. In these 30 cases, the radiologically reported median largest residual mass was 1.9 cm (range, 1.1 to 5.1), with RD more than 1 cm reported most commonly in the right upper quadrant (15 patients [50%]) and central abdomen (nine patients [30%]). Conclusion There was only a 52% correlation between surgeons' assessments and postoperative CT scan evaluations of RD in patients reported to have undergone optimal cytoreduction. Further study is required to determine whether this lack of correlation is due to rapid interval tumor regrowth, RD underestimated by the surgeons, and/or overestimated by the radiologists; and to determine the clinical implications of these discrepancies.
引用
收藏
页码:4946 / 4951
页数:6
相关论文
共 16 条
[1]   Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Podratz, KC ;
Cliby, WA .
GYNECOLOGIC ONCOLOGY, 2006, 100 (02) :283-287
[2]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[3]   Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer [J].
Axtell, Allison E. ;
Lee, Margaret H. ;
Bristow, Robert E. ;
Dowdy, Sean C. ;
Cliby, William A. ;
Raman, Steven ;
Weaver, John P. ;
Gabbay, Mojan ;
Ngo, Michael ;
Lentz, Scott ;
Cass, Ilana ;
Li, Andrew J. ;
Karlan, Beth Y. ;
Holschneider, Christine H. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) :384-389
[4]  
Bristow RE, 2000, CANCER, V89, P1532, DOI 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO
[5]  
2-A
[6]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[7]   What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? [J].
Chi, D. S. ;
Eisenhauer, E. L. ;
Lang, J. ;
Huh, J. ;
Haddad, L. ;
Abu-Rustum, N. R. ;
Sonoda, Y. ;
Levine, D. A. ;
Hensley, M. ;
Barakat, R. R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :559-564
[8]   Peritoneal metastases: Detection with spiral CT in patients with ovarian cancer [J].
Coakley, FV ;
Choi, PH ;
Gougoutas, CA ;
Pothuri, B ;
Venkatraman, E ;
Chi, D ;
Bergman, A ;
Hricak, H .
RADIOLOGY, 2002, 223 (02) :495-499
[9]   Peritoneal carcinomatosis from colorectal or appendiceal origin:: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement [J].
De Bree, E ;
Koops, W ;
Kröger, R ;
Van Ruth, S ;
Witkamp, AJ ;
Zoetmulder, FAN .
JOURNAL OF SURGICAL ONCOLOGY, 2004, 86 (02) :64-73
[10]   Optimal cytoreduction for advanced epithelial ovarian cancer: A commentary [J].
Eisenkop, Scott M. ;
Spirtos, Nick M. ;
Lin, Wei-Chien Michael .
GYNECOLOGIC ONCOLOGY, 2006, 103 (01) :329-335